Drug intelligence / Profile preview

BUCCOTHERM

Development stage: Phase 4
Lead developer: Laboratoire Odost
Modality: Small Molecules
Administration: Topical

Overview

BUCCOTHERM is an oral care product line formulated with Castéra-Verduzan thermal spring water, which is naturally alkaline (pH 8.1) and rich in mineral salts and trace elements. In clinical research conducted by I.M. Sechenov First Moscow State Medical University, the BUCCOTHERM dental spray is evaluated for its ability to neutralize oral acidity and restore salivary pH levels following the consumption of acidic beverages like Coca-Cola. By buffering the oral environment and providing essential minerals, the spray aims to prevent dental caries and tooth erosion by facilitating the remineralization of tooth enamel and protecting the oral mucosa.

Brand names: BUCCOTHERM
Other names: Dental spray BUCCOTHERMBUCCOTHERM Dental Spray

Beyond the preview

Go deeper on BUCCOTHERM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BUCCOTHERM.

Explore the full profile